The result from the validation group confirmed these findings, and also showed that serum MIC-1 levels represented a stepwise increasement in benign diseases and lung cancers in comparison with healthy controls, indicating that the overexpression of MIC-1 started likely at the development of lung cancer (Figure 1; Table 1). Here, GDF15 is linked to lung carcinoma.